Magnet zaps fat and sugar: new surgery could beat daily meds
NCT ID NCT07317115
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new magnetic device that creates a shortcut in the gut to help with weight loss and blood sugar control, comparing it to the popular drug semaglutide (Ozempic/Wegovy). Twenty adults with obesity and type 2 diabetes will be randomly assigned to either the one-time magnetic procedure or weekly injections. The goal is to see which approach better improves diabetes and weight over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Magnet System (device) and semaglutide (drug)
What this could lead to
If the magnetic procedure works, it could offer a less invasive, one-time alternative to daily medication for managing obesity and type 2 diabetes.
What could go wrong
This is a very small, early study with only 20 people. The magnetic device is experimental, and surgery always carries risks like infection or bowel leak. Results may not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY (DISORDER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Westmount Surgical Center
RECRUITINGWestmount, Quebec, H3Z 2P9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact